Valuation: Becton, Dickinson and Company

Market Cap 5TCr 4.33TCr 4.06TCr 3.7TCr 6.97TCr 4,77200Cr 7.08TCr 48TCr 19TCr 2,38900Cr 19TCr 18TCr 7,96900Cr P/E 2026 *
37.9x
P/E 2027 * 22.2x
Enterprise Value 6.59TCr 5.71TCr 5.35TCr 4.88TCr 9.19TCr 6,28800Cr 9.33TCr 63TCr 25TCr 3,14800Cr 25TCr 24TCr 10,50100Cr EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.24x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.17%
1 day-0.72%
1 week+3.11%
Current month+10.24%
1 month+18.69%
3 months+26.63%
6 months+3.80%
Current year-5.92%
1 week 173.29
Extreme 173.2937
185.32
1 month 148.34
Extreme 148.34
185.32
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
283.78
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
06/08/26 Free

Director

189 0.0001%
06/08/26 Free

Director

94 0.0000%
27/07/26 Sell

Executive/Senior Manager

-75 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%+3.11%-6.83%-35.40% 5TCr
+0.16%+2.85%-14.19%+4.66% 19TCr
-0.02%+5.67%-2.28%+9.18% 12TCr
-1.03%-4.24%+6.94%+65.87% 6TCr
+2.11%+2.55%+34.34%+62.10% 5.46TCr
+0.58%+9.97%+14.18%-21.13% 3.43TCr
+1.80%+4.55% - - 3.11TCr
-1.55%-0.34%+41.09%-13.13% 2.48TCr
+0.85%+14.53%-3.89%+20.23% 2.41TCr
-0.24%+1.81%-4.49%+2.99% 2.31TCr
Average +0.20%+4.04%+7.21%+10.60% 6.1TCr
Weighted average by Cap. +0.17%+4.20%+0.47%+12.16%

Financials

2026 *2027 *
Net sales 1.93TCr 1.67TCr 1.57TCr 1.43TCr 2.69TCr 1,84100Cr 2.73TCr 18TCr 7.21TCr 92TCr 7.24TCr 7.09TCr 3,07400Cr 1.97TCr 1.71TCr 1.6TCr 1.46TCr 2.75TCr 1,88300Cr 2.79TCr 19TCr 7.37TCr 94TCr 7.41TCr 7.25TCr 3,14500Cr
Net income 136.23Cr 118.08Cr 110.7Cr 100.93Cr 189.91Cr 13TCr 192.96Cr 1.3TCr 508.85Cr 6.51TCr 511.45Cr 500.37Cr 22TCr 215.7Cr 186.97Cr 175.27Cr 159.81Cr 300.7Cr 21TCr 305.52Cr 2.06TCr 805.68Cr 10TCr 809.8Cr 792.27Cr 34TCr
Net Debt 1.59TCr 1.38TCr 1.29TCr 1.18TCr 2.21TCr 1,51600Cr 2.25TCr 15TCr 5.93TCr 76TCr 5.96TCr 5.83TCr 2,53200Cr 1.4TCr 1.21TCr 1.13TCr 1.03TCr 1.94TCr 1,33200Cr 1.98TCr 13TCr 5.21TCr 67TCr 5.24TCr 5.12TCr 2,22300Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
14/26/14 $182.66 -0.50% 10,00,504
12/26/12 $183.58 +1.20% 15,51,548
11/26/11 $181.41 +0.99% 15,15,559
10/26/10 $179.63 +1.57% 17,65,859
07/26/07 $176.86 -0.12% 18,52,007
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
183.58USD
Average target price
194.45USD
Spread / Average Target
+5.92%

Quarterly revenue - Rate of surprise